Kestra Advisory Services’s VanEck Biotech ETF BBH Stock Holding History

Kestra Advisory Services’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$640K	Buy	3,405 +98	+3%	+$18.9K	﹤0.01%	2036
2025 Q4	$626K	Sell	3,307 -22	-0.7%	-$4.07K	﹤0.01%	1982
2025 Q3	$552K	Sell	3,329 -199	-6%	-$32.4K	﹤0.01%	1991
2025 Q2	$541K	Sell	3,528 -103	-3%	-$15.3K	﹤0.01%	1912
2025 Q1	$571K	Sell	3,631 -937	-21%	-$152K	﹤0.01%	1728
2024 Q4	$717K	Sell	4,568 -851	-16%	-$143K	﹤0.01%	1620
2024 Q3	$961K	Sell	5,419 -192	-3%	-$34.1K	0.01%	1345
2024 Q2	$945K	Buy	5,611 +192	+4%	+$31.4K	0.01%	1352
2024 Q1	$901K	Buy	5,419 +9	+0.2%	+$1.49K	0.01%	1303
2023 Q4	$894K	Buy	5,410 +2,349	+77%	+$362K	0.01%	1184
2023 Q3	$477K	Buy	3,061 +424	+16%	+$67.7K	﹤0.01%	1398
2023 Q2	$412K	Buy	2,637 +202	+8%	+$32.3K	﹤0.01%	1425
2023 Q1	$395K	Sell	2,435 -15,918	-87%	-$2.58M	﹤0.01%	1404
2022 Q4	$2.93M	Sell	18,353 -1,668	-8%	-$264K	0.03%	607
2022 Q3	$2.82M	Buy	20,021 +2,165	+12%	+$327K	0.03%	544
2022 Q2	$2.6M	Sell	17,856 -6,299	-26%	-$938K	0.03%	575
2022 Q1	$3.92M	Sell	24,155 -226	-0.9%	-$36.6K	0.04%	440
2021 Q4	$4.62M	Sell	24,381 -474	-2%	-$91.4K	0.05%	400
2021 Q3	$5.02M	Sell	24,855 -5,987	-19%	-$1.26M	0.05%	388
2021 Q2	$6.22M	Sell	30,842 -11,253	-27%	-$2.1M	0.07%	309
2021 Q1	$7.38M	Buy	42,095 +1,440	+4%	+$260K	0.09%	247
2020 Q4	$6.9M	Buy	40,655 +5,376	+15%	+$886K	0.08%	269
2020 Q3	$5.72M	Buy	+35,279	New	+$5.74M	0.11%	225

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

Kestra Advisory Services's BBH Position: Q1 2026 in Review

Kestra Advisory Services increased its VanEck Biotech ETF (BBH) stake by 3% in Q1 2026, buying an estimated $18.9K and bringing the position to 3,405 shares worth $640K. The position accounts for ﹤0.01% of the portfolio, ranked #2036.

Kestra Advisory Services first reported a position in BBH in Q3 2020 and has held it in 23 quarters since. The position peaked at $7.38M in Q1 2021. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

Kestra Advisory Services held 3,405 shares of VanEck Biotech ETF worth $640K as of Q1 2026.
Kestra Advisory Services bought 98 VanEck Biotech ETF shares in Q1 2026, an estimated $18.9K.
VanEck Biotech ETF made up ﹤0.01% of Kestra Advisory Services's portfolio in Q1 2026, its #2036 holding.
Kestra Advisory Services first reported a position in VanEck Biotech ETF in Q3 2020 and has held it in 23 quarters since.
Kestra Advisory Services's VanEck Biotech ETF position peaked at $7.38M in Q1 2021.
112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.